Unknown

Dataset Information

0

Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent.


ABSTRACT: Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the potential this model system has to offer. We endeavoured to produce a protocol for improved transfection of hPSC-CMs using the ViafectTM reagent by Promega. Through optimisation of four essential parameters: (i) serum supplementation, (ii) time between replating and transfection, (iii) reagent to DNA ratio and (iv) cell density, we were able to successfully transfect hPSC-CMs to ~95% efficiencies. Transfected hPSC-CMs retained high purity and structural integrity despite a mild reduction in viability, and preserved compatibility with phenotyping assays of hypertrophy. This protocol greatly adds value to the field by overcoming limited transfection efficiencies of hPSC-CMs in a simple and quick approach that ensures sustained expression of transfected genes for at least 14 days, opening new opportunities in mechanistic discovery for cardiac-related diseases.

SUBMITTER: Bodbin SE 

PROVIDER: S-EPMC7564709 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent.

Bodbin Sara E SE   Denning Chris C   Mosqueira Diogo D  

Methods and protocols 20200809 3


Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the potential this model system has to offer. We endeavoured to produce a protocol for improved transfection of hPSC-CMs using the Viafect<sup>TM</sup> reagent by Promega. Through optimisation of four essent  ...[more]

Similar Datasets

| S-EPMC8880351 | biostudies-literature
| S-EPMC4476236 | biostudies-literature
| S-EPMC5940117 | biostudies-literature
2018-08-09 | MSV000082810 | MassIVE
| S-EPMC5153662 | biostudies-literature
| S-EPMC6502800 | biostudies-literature
| S-EPMC7733025 | biostudies-literature
| S-EPMC2884313 | biostudies-literature
| S-EPMC7007239 | biostudies-literature
| S-EPMC3873327 | biostudies-literature